2025
Hospital-Based Methadone and Buprenorphine Initiation Practices by Addiction Consult Services
Cohen S, Straus E, Fiellin D, Pomeranz J, Suzuki J, Tetrault J, Weimer M, Edelman E, Joudrey P. Hospital-Based Methadone and Buprenorphine Initiation Practices by Addiction Consult Services. JAMA Network Open 2025, 8: e2526077. PMID: 40773194, PMCID: PMC12332638, DOI: 10.1001/jamanetworkopen.2025.26077.Peer-Reviewed Original ResearchMeSH KeywordsAdultBuprenorphineCross-Sectional StudiesDose-Response Relationship, DrugDrug Administration ScheduleFemaleFentanylHospitals, TeachingHumansMaleMethadoneMiddle AgedNarcotic AntagonistsOpiate Substitution TreatmentOpioid-Related DisordersPhysician ExecutivesPractice Guidelines as TopicReferral and ConsultationSurveys and QuestionnairesUnited StatesConceptsInitiation of methadoneAddiction consult servicesMethadone initiationBuprenorphine initiationOpioid use disorderHigh dosesLow dosesAddiction medicineLow-dose initiationFull-agonist opioidsUp-titrationCross-sectional survey studyInitiation regimenFentanyl usePrimary outcomeDay 1OpioidBuprenorphineHospital-based practiceUse disorderClinical casesClinical guidelinesMethadoneSynthetic opioidsDose
2006
A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care
Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 2006, 43: s184-s190. PMID: 17109305, DOI: 10.1086/508182.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, SublingualAdultAntiretroviral Therapy, Highly ActiveBuprenorphineDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHIV InfectionsHumansMaleMiddle AgedNaloxoneNarcotic AntagonistsOpioid-Related DisordersPilot ProjectsProbabilityReference ValuesRisk FactorsTreatment OutcomeConceptsHIV clinical careHIV-1 RNA copies/mLBuprenorphine/naloxone treatmentRNA copies/mLCopies/mLOpioid dependenceClinical careOpioid useNaloxone treatmentPhysician managementTreatment retentionHIV type 1 RNA levelsHIV-1 RNA levelsDose of buprenorphinePartial opioid agonistRNA levelsCD4 lymphocyte countBuprenorphine/naloxoneOpioid-dependent patientsUrine toxicology testsWeeks of treatmentHuman immunodeficiency virusUrine test resultsBetter treatment retentionUntreated opioid dependence
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply